Marije Slingerland

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken et al. · The Lancet Oncology · 2018 · 562 citations

Surgical Oncology, Chemotherapy Versus Chemoradiotherapy, Gastrointestinal Oncology +8

Androgen deprivation therapy for androgen receptor‐positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands

Eline Boon, Wim van Boxtel, Jan Buter et al. · Head & Neck · 2017 · 113 citations · Full text

Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation

Maja J.A. de Jonge, Marije Slingerland, Walter J. Loos et al. · European Journal of Cancer · 2010 · 90 citations

Lipid Preparation, Early Cessation, Liposomal Cisplatin Formulation +4

Bioequivalence of Liposome-Entrapped Paclitaxel Easy-To-Use (LEP-ETU) Formulation and Paclitaxel in Polyethoxylated Castor Oil: A Randomized, Two-Period Crossover Study in Patients With Advanced Cancer

Marije Slingerland, Henk‐Jan Guchelaar, Hilde Rosing et al. · Clinical Therapeutics · 2013 · 86 citations

Lipid Preparation, Advanced Cancer, Polymer-drug Conjugate +10

Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study

Karlijn de Joode, Daphne W. Dumoulin, Jolien Tol et al. · European Journal of Cancer · 2020 · 77 citations · Full text

Epidemiology, Cancer Epidemiology, Medicine +10